Arsenale Bioyards funding news – Milan-based Arsenale Bioyards Secures €9.5 Million in Seed Funding

The round was led by Planet A and byFounders, with support from CDP Ventures, Acequia Capital, Plug N Play, Grey Silo Ventures, and some industrial family offices.

Massimo Portincaso, CEO and Co-founder of Arsenale Bioyards said, “Arsenale is not only imagining the bio-economy of the future—we are building it today, with operational facilities and proprietary technology, This funding reinforces our ability to drive measurable change and underscores our aspiration to build a new generative, biology-driven industrial paradigm.”

The founding team of Arsenale brings together experts in engineering, biotech, AI, and industrial technologies.

It’s goal is to take innovations from the lab and scale them up for industrial production. The company helps industries like food, chemicals, and materials create and grow bio-based alternatives to petrochemicals and animal products.

This funding will help Arsenale transform the €191 billion biomanufacturing market and drive a shift toward a more sustainable, biology-based future.

Precision Fermentation is a key technology in biomanufacturing that uses microorganisms like yeast or bacteria to produce proteins and other valuable compounds. While it's often used in pharmaceuticals, its use in food and cosmetics is limited by high costs.

It’s platform aims to cut costs and production time by up to 90%, making it easier to adopt sustainable bio-based alternatives. The core of this platform is the Bioyards, modular bio-reactors that allow for more cost-effective scaling by expanding out, instead of just increasing size.

Christoph Gras, Co-founder & General Partner, Planet A Ventures said,
“At Planet A, we saw Arsenale’s potential early on—this is a fundamental rethink of how biomanufacturing scales. By making production cost-competitive and standardized, Arsenale turns biomanufacturing into an investable asset class while enabling industries to move away from animal- and petrochemical-derived products at scale,”.

It uses a data-driven approach to collect real-time information that helps guide experiments and predict how well they will perform on a larger scale. This allows for better control of bioreactors. By creating its own bioreactors, Arsenale ensures they work smoothly with AI models, speeding up production and reducing costs.

It’s method eliminates unnecessary lab experiments, lowers operational and capital expenses, and speeds up time to market through automation and smart design.

The company runs a pilot site with 1,000L precision fermentation capacity, including two 500L bioreactors and smaller ones with advanced sensing technology.

Read also - Pixel Photonics funding news – Munster-based DeepTech Startup Pixel Photonics Secures €1 Million in Funding

The new funding will help Arsenale expand its infrastructure, moving forward with its plans to grow in the food and cosmetics industries, and contribute to a more sustainable, innovative industrial future.

About Arsenale

Arsenale, founded in 2023 by Massimo Portincaso, Gordana Djordjevic, Niels Agerbaek, Matteo Zanotto, and Arnaud Legris, is changing bio-manufacturing with its platform that combines advanced hardware, AI software, and precision fermentation.